Waldenstrom Macroglobulinemia Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Waldenstrom Macroglobulinemia.
Found 1 Approved Drug for Waldenstrom Macroglobulinemia
Brukinsa
Generic Name
Zanubrutinib
Brukinsa
Generic Name
Zanubrutinib
Form: Capsule
Method of administration: Oral
FDA approval date: November 14, 2019
Classification: Kinase Inhibitor
BRUKINSA is a kinase inhibitor indicated for the treatment of adult patients with: Mantle cell lymphoma (MCL) who have received at least one prior therapy.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances